Allergy, Asthma & Sinus Center, S.C. Site Number : 8400088

The trials here

What the trial at this site is about, from its registry record.

Conditions

• COPD

Closed trials

• Completed

  Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation

  NCT04456673· Phase 3· Sanofi· Source